Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Hemofilie B; nog steeds on track?

317 Posts
Pagina: «« 1 ... 11 12 13 14 15 16 | Laatste | Omlaag ↓
  1. flosz 5 maart 2020 19:07
    Etranacogene Dezaparvovec

    There’s been a medical breakthrough in the treatment of haemophilia

    The first person in Ireland with the condition has been treated using gene therapy

    haemophilia.ie/first-person-with-haem...

    www.irishtimes.com/news/ireland/irish...

    twitter.com/kev_omahony/status/123555...
  2. Vitavita 25 juni 2020 17:16
    ir.catalystbiosciences.com/news-relea...

    "Studies of CB 2679d-GT in hemophilia B mice have demonstrated a 4-fold reduction in blood loss and an 8-fold reduction in bleeding time when compared with the same dose of the Padua variant of FIX. Furthermore, when packaged in a proprietary chimeric AAV capsid, CB 2679d-GT demonstrated a clear dose response of high stable FIX levels across the three dose levels in hemophilia B mice."
  3. flosz 4 november 2020 16:25
    $QURE #ASH2020 A Single Administration of AAV5-hFIX in Newborn, Juvenile and Adult Mice Leads to Stable hFIX Expression up to 18 Months after Dosing twitter.com/floszcrxl/status/13240075...

    $QURE #ASH2020 Etranacogene Dezaparvovec (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
    twitter.com/floszcrxl/status/13240077...

    $QURE #ASH2020 AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirm Stable FIX Expression and Durable Reductions in Bleeding and Factor IX Consumption for up to 5 Years
    twitter.com/floszcrxl/status/13240079...
  4. flosz 1 september 2021 21:23
    What to expect at the FDA's two-day meeting on gene therapy safety

    www.biopharmadive.com/news/fda-gene-t...

    Food and Drug Administration (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting #70
    Toxicity Risks of Adeno-associated Virus (AAV) Vectors for Gene Therapy (GT)
    September 2-3, 2021

    www.fda.gov/media/151599/download
317 Posts
Pagina: «« 1 ... 11 12 13 14 15 16 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 874,72 +0,95%
EUR/USD 1,0706 +0,51%
FTSE 100 8.032,75 +0,11%
Germany40^ 18.100,10 +1,34%
Gold spot 2.319,38 -0,34%
NY-Nasdaq Composite 15.451,31 +1,11%

Stijgers

VIVORY...
+30,53%
BAM
+4,57%
PROSUS
+4,02%
JUST E...
+3,69%
IMCD
+2,84%

Dalers

RANDST...
-6,25%
Akzo N...
-6,04%
NSI
-4,12%
FASTNED
-3,98%
Arcelo...
-2,28%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links